Influence of oxidation and multimerization on the immunogenicity of a thioredoxin-l2 prophylactic papillomavirus vaccine.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3697451)

Published in Clin Vaccine Immunol on May 15, 2013

Authors

Hanna Seitz1, Tatiana Dantheny, Frank Burkart, Simone Ottonello, Martin Müller

Author Affiliations

1: Tumor Virus-Specific Vaccination Strategies, German Cancer Research Center, Heidelberg, Germany.

Articles cited by this

Tissue sulfhydryl groups. Arch Biochem Biophys (1959) 61.89

Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67

Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer (2002) 15.46

Classification of papillomaviruses. Virology (2004) 14.16

A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet (2009) 13.51

Thioredoxin and glutaredoxin systems. J Biol Chem (1989) 8.27

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 7.24

Reassessment of Ellman's reagent. Methods Enzymol (1983) 5.83

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell (2000) 3.44

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet (2007) 3.10

A protective and broadly cross-neutralizing epitope of human papillomavirus L2. J Virol (2007) 2.36

Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature (1996) 2.34

Production of papillomavirus-based gene transfer vectors. Curr Protoc Cell Biol (2007) 2.25

Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. Proc Natl Acad Sci U S A (2008) 2.00

Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines. J Natl Cancer Inst (2009) 1.95

Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2. J Virol (2007) 1.70

Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Virology (2006) 1.65

Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types. Virology (2001) 1.52

The influence of virus structure on antibody responses and virus serotype formation. Immunol Today (1996) 1.50

High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Res (2009) 1.49

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology (1996) 1.45

Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines. J Virol (2009) 1.35

A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2. PLoS One (2011) 1.28

Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes. PLoS One (2009) 1.25

A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response. J Virol (2008) 1.16

Vaccines to prevent infections by oncoviruses. Annu Rev Microbiol (2010) 1.14

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate. PLoS One (2012) 1.08

Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide. J Biol Chem (2007) 1.08

Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin. Vaccine (2009) 1.05

High efficiency induction of papillomas in vivo using recombinant cottontail rabbit papillomavirus DNA. J Virol Methods (1995) 1.04

The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies. Virology (2010) 1.04

The oligomerization domain of C4-binding protein (C4bp) acts as an adjuvant, and the fusion protein comprised of the 19-kilodalton merozoite surface protein 1 fused with the murine C4bp domain protects mice against malaria. Infect Immun (2008) 1.04

Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity. J Virol (2009) 0.89

Monoclonal antibodies recognizing cross-neutralization epitopes in human papillomavirus 16 minor capsid protein L2. Virology (2012) 0.87

Oral administration of HPV-16 L2 displayed on Lactobacillus casei induces systematic and mucosal cross-neutralizing effects in Balb/c mice. Vaccine (2012) 0.86

Capsomer vaccines protect mice from vaginal challenge with human papillomavirus. PLoS One (2011) 0.83

HPV vaccines: preclinical development. Arch Med Res (2009) 0.83

Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2. Int J Cancer (2012) 0.82

Articles by these authors

Cell-wall recovery after irreversible deformation of wood. Nat Mater (2003) 3.09

Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog (2006) 2.65

Périgord black truffle genome uncovers evolutionary origins and mechanisms of symbiosis. Nature (2010) 2.61

JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia. Lancet Oncol (2007) 2.44

HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods (2002) 1.97

Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques. PLoS Pathog (2009) 1.92

Oxidation-responsive polymeric vesicles. Nat Mater (2004) 1.82

RIM-binding protein, a central part of the active zone, is essential for neurotransmitter release. Science (2011) 1.59

Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke: a prospective comparison of validated prognostic scores. Stroke (2010) 1.55

Insulators, not Polycomb response elements, are required for long-range interactions between Polycomb targets in Drosophila melanogaster. Mol Cell Biol (2010) 1.47

Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus. J Neurosci (2006) 1.45

In vitro versus in vivo cellulose microfibrils from plant primary wall synthases: structural differences. J Biol Chem (2002) 1.44

Structure and physical properties of [micro-tris(1,4-bis(tetrazol-1-yl)butane-N4,N4')iron(II)] bis(hexafluorophosphate), a new Fe(II) spin-crossover compound with a three-dimensional threefold interlocked crystal lattice. Inorg Chem (2004) 1.39

Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. J Gen Virol (2008) 1.35

The significance of direct sunlight and polarized skylight in the ant's celestial system of navigation. Proc Natl Acad Sci U S A (2006) 1.35

Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70. J Virol (2004) 1.27

Prediction of left ventricular remodeling and analysis of infarct resorption in patients with reperfused myocardial infarcts by using contrast-enhanced MR imaging. Radiology (2007) 1.21

The Mcp element mediates stable long-range chromosome-chromosome interactions in Drosophila. Mol Biol Cell (2006) 1.21

A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response. J Virol (2008) 1.16

Homeostatic control of presynaptic neurotransmitter release. Annu Rev Physiol (2014) 1.16

Production of human papillomavirus type 16 virus-like particles in transgenic plants. J Virol (2003) 1.15

Intragenic promoter adaptation and facilitated RNA polymerase III recycling in the transcription of SCR1, the 7SL RNA gene of Saccharomyces cerevisiae. J Biol Chem (2001) 1.15

Human dimensions of forest disturbance by insects: an international synthesis. Environ Manage (2008) 1.14

Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology (2004) 1.13

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice. J Virol (2003) 1.12

Checkers is solved. Science (2007) 1.10

Differential expression of a metallothionein gene during the presymbiotic versus the symbiotic phase of an arbuscular mycorrhizal fungus. Plant Physiol (2002) 1.08

The anti-HIV cyanovirin-N domain is evolutionarily conserved and occurs as a protein module in eukaryotes. Proteins (2005) 1.08

Truffle volatiles: from chemical ecology to aroma biosynthesis. New Phytol (2011) 1.08

Domain organization of phytochelatin synthase: functional properties of truncated enzyme species identified by limited proteolysis. J Biol Chem (2004) 1.08

Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide. J Biol Chem (2007) 1.08

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate. PLoS One (2012) 1.08

Upregulation of inward rectifier K+ (Kir2) channels in dentate gyrus granule cells in temporal lobe epilepsy. J Physiol (2009) 1.08

Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1. J Virol (2006) 1.06

Mechanical properties of silk: interplay of deformation on macroscopic and molecular length scales. Phys Rev Lett (2008) 1.05

A general one-step method for the cloning of PCR products. Biotechnol Appl Biochem (2005) 1.05

Coordinated binding of Vps4 to ESCRT-III drives membrane neck constriction during MVB vesicle formation. J Cell Biol (2014) 1.05

A composite upstream sequence motif potentiates tRNA gene transcription in yeast. J Mol Biol (2003) 1.05

Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin. Vaccine (2009) 1.05

Characterization of the mechanical properties of qPlus sensors. Beilstein J Nanotechnol (2013) 1.05

The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies. Virology (2010) 1.04

The evolutionarily conserved family of cyanovirin-N homologs: structures and carbohydrate specificity. Structure (2008) 1.04

DNA-vaccination via tattooing induces stronger humoral and cellular immune responses than intramuscular delivery supported by molecular adjuvants. Genet Vaccines Ther (2008) 1.03

A nick-sensing DNA 3'-repair enzyme from Arabidopsis. J Biol Chem (2002) 1.03

A presynaptic ENaC channel drives homeostatic plasticity. Neuron (2013) 1.03

Increasing amino acid supply in pea embryos reveals specific interactions of N and C metabolism, and highlights the importance of mitochondrial metabolism. Plant J (2008) 1.02

Distribution and determinants of functioning and disability in aged adults--results from the German KORA-Age study. BMC Public Health (2013) 1.02

The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter. J Exp Med (2013) 1.01

Membrane transporters and protein traffic networks differentially affecting metal tolerance: a genomic phenotyping study in yeast. Genome Biol (2008) 1.00

Determination of insecticidal Cry1Ab protein in soil collected in the final growing seasons of a nine-year field trial of Bt-maize MON810. Transgenic Res (2011) 0.99

Enhancer blocking and transvection at the Drosophila apterous locus. Genetics (2008) 0.99

TBX3 Directs Cell-Fate Decision toward Mesendoderm. Stem Cell Reports (2013) 0.98

Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques. Hum Gene Ther (2012) 0.98

The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study. BMC Neurol (2011) 0.98

Gene expression profiling in human age-related nuclear cataract. Mol Vis (2003) 0.97

Solanezumab for the treatment of mild-to-moderate Alzheimer's disease. Expert Rev Clin Immunol (2012) 0.97

Structure-function analysis of a CVNH-LysM lectin expressed during plant infection by the rice blast fungus Magnaporthe oryzae. Structure (2011) 0.97

A high-affinity ammonium transporter from the mycorrhizal ascomycete Tuber borchii. Fungal Genet Biol (2002) 0.97

Graphical models illustrated complex associations between variables describing human functioning. J Clin Epidemiol (2009) 0.95

Generalized epidemic process and tricritical dynamic percolation. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 0.95

Conformational and dynamical properties of disaccharides in water: a molecular dynamics study. Biophys J (2006) 0.95

The γ-secretase modulator CHF5074 restores memory and hippocampal synaptic plasticity in plaque-free Tg2576 mice. J Alzheimers Dis (2011) 0.95

Glial-derived prodegenerative signaling in the Drosophila neuromuscular system. Neuron (2011) 0.94

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Eur J Pediatr (2005) 0.94

Amino acid metabolism at the maternal-filial boundary of young barley seeds: a microdissection-based study. Planta (2009) 0.94

High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses. PLoS One (2013) 0.93

The ICF forms a useful framework for classifying individual patient goals in post-acute rehabilitation. J Rehabil Med (2011) 0.93

Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice. BMC Neurosci (2013) 0.92

Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes. Virology (2007) 0.92

Secretory phospholipases A2 induce neurite outgrowth in PC12 cells through lysophosphatidylcholine generation and activation of G2A receptor. J Biol Chem (2005) 0.92

Patient goals in post-acute geriatric rehabilitation--goal attainment is an indicator for improved functioning. J Rehabil Med (2011) 0.92

Distinctive properties and expression profiles of glutamine synthetase from a plant symbiotic fungus. Biochem J (2003) 0.91

Ability of Bifidobacterium breve to grow on different types of milk: exploring the metabolism of milk through genome analysis. Appl Environ Microbiol (2011) 0.91

Health services utilization of patients with vertigo in primary care: a retrospective cohort study. J Neurol (2014) 0.91

Interaction of human papillomavirus type 16 L2 with cellular proteins: identification of novel nuclear body-associated proteins. Virology (2002) 0.90

ADP-glucose pyrophosphorylase-deficient pea embryos reveal specific transcriptional and metabolic changes of carbon-nitrogen metabolism and stress responses. Plant Physiol (2008) 0.90

Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Virology (2002) 0.90

Protein resistance of PNIPAAm brushes: application to switchable protein adsorption. Langmuir (2010) 0.90

Phenotype severity in the bladder exstrophy-epispadias complex: analysis of genetic and nongenetic contributing factors in 441 families from North America and Europe. J Pediatr (2011) 0.89

Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity. J Virol (2009) 0.89

Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity. Vaccine (2009) 0.89

Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial. J Neurol (2012) 0.89

Functional properties and differential mode of regulation of the nitrate transporter from a plant symbiotic ascomycete. Biochem J (2006) 0.88

Structure and mechanical properties of carbon fibres: a review of recent microbeam diffraction studies with synchrotron radiation. J Synchrotron Radiat (2005) 0.88

A dominant vimentin mutant upregulates Hsp70 and the activity of the ubiquitin-proteasome system, and causes posterior cataracts in transgenic mice. J Cell Sci (2008) 0.88

Development of neutralizing monoclonal antibodies for oncogenic human papillomavirus types 31, 33, 45, 52, and 58. Clin Vaccine Immunol (2014) 0.88

Agrobacterium-mediated gene transfer and enhanced green fluorescent protein visualization in the mycorrhizal ascomycete Tuber borchii: a first step towards truffle genetics. Curr Genet (2005) 0.88

The significance of the Golgi complex in envelopment of bovine herpesvirus 1 (BHV-1) as revealed by cryobased electron microscopy. Micron (2002) 0.88

A 17-year-old girl with a black eschar. Cowpox virus infection. Clin Infect Dis (2009) 0.88

Consequences of visual height intolerance for quality of life: a qualitative study. Qual Life Res (2013) 0.88

Patients' view on health-related aspects of functioning and disability of joint contractures: a qualitative interview study based on the International Classification of Functioning, Disability and Health (ICF). Disabil Rehabil (2014) 0.87

Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes. Plant Biotechnol J (2011) 0.87

Electrostatic interactions modulate the conformation of collagen I. Biophys J (2007) 0.87

In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents. Pharmacol Res (2007) 0.87

Enhanced papillomavirus-like particle production in insect cells. Virology (2009) 0.87

Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly. Vaccine (2005) 0.87

Positive modulation of RNA polymerase III transcription by ribosomal proteins. Biochem Biophys Res Commun (2008) 0.87

Swine adipose stromal cells loaded with recombinant bovine herpesvirus 4 virions expressing a foreign antigen induce potent humoral immune responses in pigs. Vaccine (2010) 0.86